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For many years the study ofcellular immunology was impeded by the inability
to propagate and expand homogeneous populations of antigen-specific lympho-
cytes in vitro. Inthe mid-1970's, Kohler and Milstein (1, 2) developeda technique
that allowed the immortalization of antigen-specific B cells by fusing them to
transformed and spontaneously proliferating myeloma cells, thereby producing
B cell hybridomas. Hybridoma technology was subsequently applied to T lym-
phocytes, providing a convenient source of T cells for in vitro study (3-5), and
theestablishment ofantigen-specific Tcell hybridomas madeit possible to analyze
the requirements for antigenic stimulation in model systems (6). Murine antigen-
specific T cell hybridomas are commonly prepared by using polyethylene glycol
to fuse antigen-primed T cell blasts to the spontaneously proliferating AKR-
derived thymoma, BW5147. These T cell hybridomas can be tested for their
ability to respond to the antigen used to prime the normal lymphocyte fusion
partner, and the cells that exhibit the appropriate specificity can be cloned and
expanded to large numbers.
For normal T lymphocytes, occupancy of the antigen receptor usually results
in a complex series ofactivation events that include expression ofnew cell surface
receptors, production of lymphokines, and entry ofthe cell into its growth cycle
(7). This last response is not pertinent when using T cell hybridomas, because
they are spontaneously proliferating cells. Therefore, the approach that has
generally been used to assess the result of antigen receptor occupancy of Tcell
hybridomas is to quantitate their production oflymphokines, typically IL-2 (6).
In recent years ithas becomeevident that the occupancy ofa variety ofreceptors
that typically promote growth in normal cells, e.g., occupancy of receptors for
epidermal growth factor (8), transforming growth factor ,B (9), and even IL-2
(10, 11), can inhibit the growth of certain transformed cells. We therefore
undertook an analysis of the effect of antigen-mediated activation upon the
growth of murine T cell hybridomas. We found that stimulation with antigen
resulted in a dose-dependent decrease in both [sH]thymidine incorporation and
cell growth. This phenomenon displayed the same ligand-specificity as did IL-2
production, as demonstrated by its requirement for a specific allelic form of the
la molecule, anticlonotypic (i.e., anti-antigen receptor) antibody blocking exper-
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iments, and stimulation with anticlonotypic antibodies crosslinked to Sepharose
beads . Flow cytometric analysis revealed that antigen activation produced a block
in the cell growth cycle that was predominantly at the G,/S interface, although
cells also appeared to be slowed or halted in S phase. Furthermore, with the use
of correlated DNA and surface immunofluorescence flow cytometry, it was
demonstrated that the addition of antigen to a mixture of T cells specific for
different antigens resulted in a cell cycle block in only the stimulated T cell
hybrid. The implications of this phenomenon are discussed, including its utility
as a rapid and quantitative measure of T cell hybridoma activation, as a means
of selecting T cell hybridomas that have functional mutations in the antigen-
specific receptor or elsewhere in the activation pathway, and as a possible model
for the induction of T cell tolerance.
Materials and Methods
Animals. B10.A/SgSn (B10 .A) mice were obtained from Harlan Spraque-Dawley
(Madison, WI) through a contract with the Animal Genetics Production Branch (Devel-
opmental Therapeutics Program, Division of Cancer Treatment, NCI, Frederick, MD).
BIO.D2 mice were derived from pedigreed pairs originally obtained from Dr. Jack
Stimpfling, Great Falls, MT. Mice of either sex were used between the ages of 2-12 mo.
Antigens. Pigeon cytochrome c, chicken ovalbumin, and hen egg lysozyme (HEL)'
were purchased from Sigma Chemical Co. (St. Louis, MO). The random terpolymer poly-
(Glus -Alas°-Tyr'o) (GAT) was purchased from Vega Biochemicals (Tucson, AZ). The
COOH-terminal pigeon cytochrome c fragment 81-104 was prepared by CNBr cleavage
as described (12).
Antibodies.
￿
10-2.16 is a murine IgG2b antibody that binds the Ao':A. la molecule (13) .
14.4.4 is a murine IgG2a antibody that recognizes the EO':E, la molecule (14). Both
antibodies were prepared as ascites and used at a final dilution of 1 :500 (vol/vol). A2134-
2 is a murine IgG2a antibody that binds the antigen-specific receptor borne by the T cell
hybridoma 2134 (15). Ascites containing A2B4-2 was purified by sequential passage over
columns of DEAE Affi-Gel Blue (Bio-Rad, Richmond, CA) and protein A-Sepharose
(Pharmacia Fine Chemicals, Uppsala, Sweden). The purified antibody was coupled to
activated Sepharose (Pharmacia Fine Chemicals) at a concentration of 2 mg/ml (deter-
mined spectrophotometrically), and was the generous gift of Drs. H. Narimatsu and R.
Schwartz (National Institute of Allergy and Infectious Diseases, NIH). For the blocking
experiments, the anticlonotypic antibody A2B4-2 was purified from ascites in a single step
by passage over a protein A-Sepharose column, and was kindly provided by Dr. B. Fox
(National Institute of Allergy and Infectious Diseases, NIH).
T Cell Hybridoms.
￿
All of the T cell hybridomas used in this study were obtained by
polyethylene glycol-mediated fusion of antigen-primed lymph node T cells to the AKR-
derived thymoma BW5147 as described (16). The strain and haplotype of the BW5147
fusion partners, the antigen/la molecule specificity of the hybridomas, and a reference in
which each hybridoma was described are given in Table I . The T cells 2114.11 and C 10 .9
were obtained by subcloning the 2134 and C 10 lines, respectively, at limiting dilution, and
were selected for use in these studies because oftheir stability asjudged by their functional
responses, and in the case of 2134.11, the homogeneous expression of the antigen-specific
receptor. The T cell hybridomas A4.AIA and A6.A2.7 were obtained by subcloning the
A4.A1 and A6.A2 lines, respectively, at limiting dilution, and were selected for their
superior ability to produce IL-2 compared to the parent cell line. All of the T cell
hybridomas were maintained in exponential growth in a medium consisting of RPMI
1640 (Biofluids, Rockville, MD) supplemented with 10% heat-inactivated fetal calfserum,
'Abbreviations used in this paper:
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CTLL, IL-2-dependent cytotoxic T cell line; EGF, epidermal
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4 mM glutamine, 100 U/ml penicillin, 150 jug/ml gentamicin, and 50 uM 2-ME (growth
medium).
Stimulation of T Cell Hybridomas.
￿
5-10 X 10s T hybridoma cells were cultured in
duplicate or triplicate in 96-well, flat-bottomed microtiter plates (3596; Costar, Cam-
bridge, MA) in a final volume of a 50:50 (vol/vol) mixture of RPMI 1640 (Biofluids) and
Eagle's-Hank's amino acid (EHAA) medium (MA Bioproducts, Walkersville, MD) supple-
mented as above (complete medium). In the case ofantigen stimulation, 5 X 105 irradiated
(3300 rad) splenocytes were added to each well along with the indicated concentrations
of antigen. Stimulation with antibody-coupled beads was performed by resuspending a
50:50 (vol/vol) slurry of A2114-2-coupled Sepharose beads and removing the volumes
indicated. The beads were washed with PBS three times, resuspended in complete
medium, and added to the T cellsin the absence ofany other cell type (i.e., no splenocytes
were present).
IL-2 Assay.
￿
After 24 h of culture, 50 al of supernatant was removed from each well
and frozen to ensure that no viable cells were included. The IL-2 content was determined
by incubating an IL-2-dependent T cell line (CTLL) at 3 X 10' cells/well with twofold
serial dilutions of the supernatant. After ^-20 h, the CTLL were pulsed with 1 jCi of
[3H]thymidine per well (6.7 Ci/mmol; ICN, Irvine, CA) and, after another 8 h, were
precipitated onto glass filter strips with the use of a semiautomated cell harvester (PHD
Cell Harvester; Cambridge Technology, Cambridge, MA). The incorporation of [6H]-
thymidine was determined by liquid scintillation counting. One unit of IL-2 activity is
defined as that dilution of supernatant capable of stimulating the IL-2-dependent T cell
to half of its maximal proliferative response.
/3HJThymidine Incorporation by T Cell Hybridomas.
￿
At 24 h of culture, after 50 MI of
supernatant had been removed for the measurement of IL-2, I /Ci of [sH]thymidine was
added to each T cell hybridoma-containing well (5-10 X 10' cells/well in 150 Ml). 2-3 h
later the wells were harvested as above, and [6H]thymidine incorporation was assessed by
liquid scintillation counting.
Cell Counting.
￿
2114.11 or C 10.9 T cells were placed in 96-well flat-bottomed plates at
a density of 5 X 10' cells/ml in complete medium. 5 X 105 irradiated (3,300 rad) BIO.A
(syngeneic), or B10.D2 (allogeneic), splenocytes were added to each well as a source of
APC, along with varying amounts of the appropriate antigen. At 24-h intervals, three
wells were resuspended by gentle pipetting, 10-20-wl aliquots were removed, and viable
cells were counted in the presence of 0 .4% trypan blue stain (Gibco Laboratories, Grand
Island, NY) by light microscopy. T hybridoma cells were easily differentiated from the
irradiated splenocytes on the basis of morphology and the exclusion of trypan blue dye.
The standard error of these determinations was always <10%.
Flow Cytometry.
￿
T cell hybridomas were cultured at 4 X 105 cells/ml in 5-ml plastic
tubes (Becton Dickinson, Oxnard, CA) containing 5 X 106 irradiated (3,300 rad) B10.A
splenocytes in the presence or absence of antigen. After 24 h, viable cells were isolated
by recovery from a Lympholyte-M density gradient (Cederlane Laboratories, Ontario,
Canada), washed in saline G (PBS containing 1 g/liter glucose without any calcium or
magnesium, prepared by the NIH media unit), and the cell pellet was fixed by slowly
adding chilled absolute ethanol while vigorously mixing the cells. After fixing for 2-24 h
in ethanol, the cells were centrifuged, washed in saline G, and resuspended in saline G
containing 1 mg/ml of RNase A (Worthington Biochemicals, Freehold, NJ) and 18 lug/ml
of propridium iodide (Sigma Chemical Co.). The cells were allowed to equilibrate for at
least 1 h before being analyzed for cellular DNA content with a Cytofluorograf System
50 (Ortho Diagnostic Systems, Westwood, MA) using 488-nm excitation at 200 mW.
Doublets and higher aggregateswere excluded from analysis by using correlated area/peak
measurements of DNA content similar to that described previously (21). Cell cycle analyses
were done by the polynomial model of Dean and Jett (22). Cell size was simultaneously
measured by using axial extinction at 633 nm from a 0.8 mW helium-neon laser. For
correlated DNA/surface immunofluorescence measurements, ^-1-2 X 106 2114.11 or
C10 .9 cells (or a mixture of both) were incubated in HBSS (Biofluids) containing 0.2%
NaN5 , I % fetal calf serum; and with or without 100 kl of A2114-2 culture supernatant (a176
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saturating concentration, data not shown) for 30 min at VC. C. The cells were washed three
times and incubated with 5 ;tg of affinity-purified fluoresceinated goat anti-mouse Ig
F(ab')2 (Cappel Laboratories, West Chester, PA)for 45 minat 4°C. Thecells were washed
twice in saline G before fixation with ethanol. Analyses were performed using a Cytofluo-
rograf System 50 at 200 mW laser power at 488 nm. Under these conditions, the red
fluorescence associated with DNA could be easily separated from the green fluorescence
associated with the cell surface A2B4-2 antigen by appropriate filtration. Contour plots
were generated using software developed by Dr. Peter Rabinovitch (University of Wash-
ington) for the Ortho 2150 computer system .
Results
Stimulation with Antigen Inhibits Uptake of [3H]Thymidine by T Cell Hybrido-
mas. In the course of studies concerning the effect of varying T cell number
upon antigen-stimulated IL-2 production, we noted that T cell hybridomas
appeared to grow more slowly in the presence of their antigen. To quantitatively
assess this phenomenon, a variety of antigen-specific T cell hybridomas were
cocultured with antigen-presenting cells (APC) and assayed for their ability to
incorporate [sH]thymidine in the presence or absence of antigen (Table I). Eight
T cell hybrids of varying antigen- and major histocompatibility complex (MHC)-
specificity were tested; all displayed a marked inhibition of ['H]thymidine incor-
poration 24-26 h after the addition of the appropriate antigen. In all cases, the
T cell hybridomas were found to produce measurable amounts of IL-2 at
concentrations of antigen that caused substantial inhibition of ['H]thymidine
incorporation. Two of the hybridomas, 2114.11 and C10.9, were chosen for
further study. 2114 .11 responds to the C001-1-terminal portion of the antigen
pigeon cytochrome c (pigeon fragment 81-104) in association with the Es- .Ea la
molecule (17), and C10.9 recognizes HEL in the presence of the Ak:Ak la
molecule (18). Antigen dose-response curves were performed in the presence of
a constant number of B10.A splenic APC, whichbear both of these la molecules
(Fig. 1). Both of the T cell hybrids exhibited a decrease in [sH]thymidine
incorporation and a corresponding increase in the amount of IL-2 produced as
the concentration of antigen was increased. In fact, similar concentrations of
antigen were required to achieve 50% inhibition of [sH]thymidine incorporation
and 50% stimulation of IL-2 release. This inversely proportional relationship
suggested that the inhibition of ['H]thymidine incorporation was a consequence
of cellular activation, and demonstrated that, for these two T cell hybridomas,
the sensitivity of this assay in detecting antigenic stimulation was comparable to
one that measures the secretion of IL-2 .
Inhibition of [ 3H]Thymidine Uptake Is a Consequence of Receptor Occupancy.
￿
A
variety of approaches were used to examine the antigen-specificity of the inhi-
bition of [sH]thymidine incorporation. First, titration of the "wrong" antigen
(either pigeon fragment 81-104 with C10.9, or HEL with 2114.11) in the
presence of B10.A APC failed to cause either IL-2 release or inhibition of [sH]-
thymidine incorporation (data not shown). Second, since these antigens must be
"corecognized" with a specific la molecule, monoclonal antibodies that bind to
the two required la molecules were tested for their effect on ['H]thymidine
incorporation (Table II). The monoclonal antibody 14 .4.4 binds to the EO:E, laASHWELL ET AL.
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TABLE I
TCell Hybridoma Proliferation and IL-2 Production upon Stimulation with Antigen
104 T cell hybridswere assessed for ['H]thymidine incorporation and IL-2 production after 24 h
of incubation, as detailed in MaterialsandMethods. The cellsshould not be compared on the basis
of absolute ['H]thymidine incorporation because the data are taken from different experiments.
* Mousestrain and haplotype of the normal Tcells used as the fusion partners for BW5147.
tThe source of splenic APC for each of the specified allelic forms of the la molecule are E~:Ea,
B10.A; Ad:Ad ., B10.D2.
§ Pigeon cytochrome c fragment 81-104 wasused in these experiments.
1 ['H]Thymidineincorporation by CTLL cellsin thepresence ofa 1:4 (25%) dilution of supernatant.
' In some experiments, the Tcell hybrid supernatants were titeredin the presence of CTLL cells to
obtain the number of IL-2 units produced,as described in Materialsand Methods.
molecule (corecognized by 2B4.11), and the monoclonal antibody 10-2.16 binds
to the AO':A', la molecule (corecognized by C10.9). The addition of 10-2.16
blocked the inhibition of[3H]thymidine incorporation observed when C10.9 was
incubated with HEL, but had no effect when added to 2B4.11 plus pigeon
fragment 81-104 (Table II). Conversely, the antibody 14.4.4 blocked the inhib-
itory effect ofthe pigeon fragment 81-104 on the [3H]thymidine incorporation
of 2B4.11 by ^-100-fold, but had no effect on the response of C10.9 to HEL.
Further evidence that it was occupancy of the T cell hybridomas' antigen-
specific receptors that resulted in inhibition of ['H]thymidine incorporation was
obtained by using the monoclonal antibody AM-2, a mouse IgG2a that recog-
nizes an epitope on theantigen receptor of2B4.11, but that is not on the antigen
receptor of C10 .9 (see reference 15 and Fig. 4, below). This antibody is an
T cell
Mouse
(haplotype)
strain Refer-
ence
la mole-
CUO
Antigen Concentration
['H]Thymi-
dine uptake
IL-2 production
cpm cpm U
2B4.11 BI0.A(H-2') 17 4:Ea Cytochromecl 0 41,900 1,1001 01
3AM 11,100 32,600 78
30 pM 5,000 35,400 >128
2H10 B10.A(H-2°) 17 Etp:Ea Cytochromec 0 84,000 1,300 0
3 AM 37,500 34,600 10
30 8M 18,700 35,400 17
2C2 BIO.A (H-2') 17 EI:E; Cytochrome c 0 89,600 800 0
3#M 71,600 44,100 70
HAM 31,100 45,900 120
CIO.9 BIO.A (H-2') 18 AI:A! HEL 0 65,000 200 0
30 gg/ml 27,900 31,000 24
300,ug/ml 11,500 35,700 38
A4.Al .4 BIO.A(H-2') 18 AI:A; HEL 0 57,300 3,800 ND
308g/ml 41,600 19,600
300wg/ml 14,300 30,300
A6.A2.7 BIO.A (H-2') 18 At p:A ; HEL 0 27,500 4,500 ND
30 kg/ml 14,600 27,900
300vg/ml 2,500 40,500
3DO.54.8 BALB/c (H-2d) 19 A$:A; Ovalbumin 0 59,000 3,000 ND
100ng/ml 10,600 11,000
1,000 vg/ml 6,100 18,000
F9.140 BALB/c (H-2d) 20 A$:A; GAT 0 26,800 2,300 ND
100kg/ml 18,800 6,600
1,000 Ag/ml 11,900 27,000178
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FIGURE 1 .
￿
Incorporation of ['H]thymidine and secretion of IL-2 as a function of antigenic
stimulation. (A) 10' 2114.11 Tcells or (B) 10' C10.9 T cellswere incubated in thepresence of
5 x 105 irradiated B10.A splenocytes and varying concentrations of the appropriate antigen.
After 24 h, an aliquot ofsupernatant wasremoved from each well forthe quantitation of IL-
2content (circles), ['H]thymidine wasadded to each well,and ['H]thymidine incorporation by
the T hybridoma cells (squares) was determined as described in Materials and Methods. In
parallel culture wells the antibody A2B4-2 was added at a final concentration of 0.63 'Ug/ml
(closed symbols).
extremely potent inhibitor of antigen-stimulated IL-2 release by 2114.11 (15).
A2B4-2 was added to an assay in which 2114 .11 was stimulated with antigen (Fig.
1). The anticlonotypic antibody blocked both the release of IL-2 and the
inhibition of [3H]thymidine incorporation. No effect was observed when similar
concentrations of A2114-2 were added to an assay performed with C10.9 .
Although the soluble form of the antibody A2114-2 exhibits no stimulatory
effect upon 284.11, when it is crosslinked to Sepharose beads it will cause
2134.11, but not other T cell hybridomas that bear unrelated antigen receptors,
to release IL-2 in a dose-dependent fashion (H . Narimatsu and R. Schwartz,
personal communication). Table III contains the results of a typical experiment
in which A2B4-2 crosslinked to Sepharosewas used to stimulate 2114.11. Whereas
soluble A2B4-2 had no stimulatory effect, the addition of A2114-2 crosslinked to
Sepharose beads resulted in both IL-2 release and inhibition of [3H]thymidine
incorporation. The antigen-specificity of these responses was demonstrated byTABLE II
Reversal ofAntigen Inhibition with Anti-Ia Monoclonal Antibodies
10' T cell hybridomas were cultured in triplicate with 5 X 105irradiated B10.A
splenocytes as APC and varying concentrations of the indicated antigen, in the
presence or absence of a 1:500 dilution of ascites containing 10-2.16 (anti-
A':A!) or 14.4.4 (anti-E,:E.). Incorporation of ['H]thymidine was determined
after 24 h in culture as described in Materialsand Methods.
ASHWELL ET AL.
TABLE III
Effect ofA2B4-2-coupled Sepharose Beads on 2B4.11 and C10.9
10' 2134.11 or C10.9 T cells were cultured in duplicate wells in the presence of
either soluble A2B4-2 antibody (0.63 ug/ml of purified antibody), varying
amounts of A2114-2-coupled Sepharose beads, or both, in a total volume of 200
pl. After 24 h, 50 kl of supernatant was removed from each well for the
determinationof IL-2 units, andthecellswere pulsed with 1jACi of [sH]thymidine
for 2 h, after which time the wells were harvested and the ['H]thymidine
incorporation determined by scintillation counting.
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the fact that both were reversed by the addition of soluble A2B4-2 . Stimulation
of the T cell 2B4.11 with pigeon fragment 81-104 in association with the E':E'
la molecule incorporated into lipid planar membranes also resulted in both IL-
2 production and growth inhibition (J. D. Ashwelland Barbara Fox, unpublished
results). Taken together, these data indicate that the occupancy (or crosslinking)
of the antigen-specific T cell receptor in the absence of any signals provided by
T cell
Antigen ['H]Thymidine incorporation after
culture with:
81-104 HEL No antibody 10-2.16 14.4.4
AM ag/ml cpm
C10.9 0 0 47,700 43,200 46,200
0 3 30,600 42,800 20,400
0 30 12,700 58,600 13,400
0 300 7,700 50,400 7,700
2134.11 0 0 55,100 52,700 68,300
0.3 0 37,500 40,000 49,700
3 0 24,400 32,200 66,500
30 0 15,600 13,800 32,500
A2134-2-cou-
pled beads
'Ul
Soluble
A2B4-2
['H]Thymidine
tion with Tcell
2134.11
cpm
incorpora-
hybridoma.
C10.9
IL-2
by T cell
doma
2134.11
U
production
hybri-
C10.9
- - 119,900 145,700 0 0
- + 113,300 158,500 0 0
0.125 - 66,900 154,000 24 0
0.25 - 64,600 148,000 36 0
0.5 - 58,300 145,200 40 0
1.0 - 44,400 143,000 46 0
2.0 - 37,900 148,700 38 0
2.0 + 112,200 154,300 0 0180
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FIGURE 2 .
￿
Flow cytometric analysis of the effect of antigen stimulation upon T cell hybri-
doma DNA content and volume . C10.9 T cells were incubated at a concentration of 3 X 10 5
cells/ml with 5 X 106 irradiated BIO .A splenocytes per milliliter in the absence (solid lines) or
presence (dotted lines) of 300,ug/ml ofHEL . After24htheT hybridoma cells were separated
from the APC by density centrifugation and fixed with ethanol . (A)DNA content was assessed
by staining with propridium iodide . The first large peak represents cells in G,, those cells with
twice theamount ofDNA are in G2 or M, and those cells that are synthesizingDNAarefound
between the two peaks, in S phase. The fraction of cells in each phase of the cell growth cycle
in the absence of antigen was, G,, 36% ; S, 62% ; and G2 Plus M, 2% . In the presence of HEL,
it was G,, 78% ; S, 20% ; and G2 Plus M, 2% . (B) Cell size was determined by axial extinction
measurements and expressed as arbitrarily defined relative units .
other cells can lead to the inhibition of [sH]thymidine incorporation by T cell
hybridomas .
Antigen Stimulation Causes a G,/S Cell Growth Cycle Block .
￿
The incorporation
of ['H]thymidine reflects both the quantity and the rate ofDNA synthesis, and
its decrease could be due to a block anywhere in a cell's growth cycle . To
determine the point(s) at which antigen stimulation blocked the cell cycle, C10 .9
T cells were incubated with irradiated APC in the presence or absence of HEL.
After 24 h the T cell hybridomas were separated from the APC by density
centrifugation and analyzed by flow cytometry (Fig . 2) . In the absence of specific
antigen (Fig . 2A, solid line), the DNA profile for C10.9 T cells was typical of
rapidly proliferating cells, with ^-36% of the cells in GI , 62% in S, and 2% in G2
and M phases of the cell cycle . The addition of the antigen HEL to the 24-h
culture caused a marked increase in mean cell size (Fig . 2B), accompanied by a
change in the DNA profile (Fig . 2A, broken line), with the majority of the cells
(78%) in GI , 20% in S, and 2% of the cells in G2 or M phase . The major effect
after stimulation with antigen thus seemed to be a cell cycle block at the GI/S
border . Similar data was obtained with the T cell 2134 .11 (data not shown; see[81-1041(pM) : 0 0.3 3 30
[HELL (yag/ml):
￿
0
￿
3
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FIGURE 3.
￿
The inhibition of fH]thymidine incorporation is evident only in the stimulated
T hybridoma cell. 5 x 109 2134.11 (p) or 010.9 (A) T cells were assayed for their ability to
incorporate the [9H]thymidine after 24 h of culture in the presence of irradiated B10.A
splenocytes and varying amountsof antigen. In parallel cultures, 5 x 109of each of thesecells
were mixed together and stimulated with either pigeon fragment 81-104 (/), HEL ("), or
both antigens simultaneously (0).
also Fig. 4, below). Asecond effect ofantigen stimulation was to cause some cells
in S phase to either slow or cease their synthesis of DNA (Fig. 2A). This
interpretation is supported by experiments in which cell cycleanalysis ofantigen-
stimulated cells was performed after 24 h and also after 48 h, in the presence or
absence of the mitotic inhibitor colcemid. It was observed that those cells found
to be in S phase at 24 h had failed to accumulate in Mphase by 48 h, suggesting
that they were no longer cycling (data not shown).
Inhibition ofGrowth Is the Result ofa Direct Effect upon the Stimulated Cell.
￿
The
cell cycle block induced by stimulation with antigen could be a direct result of
antigen receptor occupancy, or it could be secondary to the binding of soluble
substances (such as lymphotoxin) produced by the activated T cell hybrids. To
test these possibilities, equal numbers of C10.9 and 2B4.11 were assayed, both
independently and when admixed, for the effect of antigen stimulation upon
[sH]thymidine incorporation (Fig. 3). When incubated separately, the growth of
both T cell hybridomas was inhibited in an antigen dose-dependent fashion.
When mixed together in the absence of antigen the amount of [sH]thymidine
incorporated was approximately equal to the sum of the individual populations.
The addition of either antigen alone resulted in the loss of the contribution
made by the appropriate antigen-specific T cell. At maximal stimulation the
combined response was reduced by ^-50%. Thus, at concentrations of pigeon
fragment 81-104 that were shown to cause maximal growth inhibition of2114.11
(e.g., 30 1,M), the mixed population incorporated ^-26,000 cpm, and at the
comparable concentrations of HEL (300,ug/ml) the mixed population incorpo-
rated 27,000 cpm. In the presence of both antigens, however, [sH]thymidine
incorporation by the mixed population was almost completely inhibited. These
results suggested that the inhibitory effect of antigenic stimulation was direct,
being manifested only in T cells hybridomas in which the antigen receptors were
engaged.
To further analyze the potential for a secreted inhibitor of growth, we made182
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FIGURE 4 . Cell growth cycle blockade after antigenic stimulation is evident only in the
stimulated T hybridoma cell . (A and B) 3 X 10 5 2114.11 T cells/ml were incubated with 5 X
10 8 irradiated BIO.A splenocytes in the absence (A) or presence (B) of 100AM pigeon fragment
81-104 . (C and D) 3 X 105 C10.9 T cells/ml were incubated with 5 X 108 irradiated BIO.A
splenocytes in the absence (C) or presence (D) of 300 jig/ml ofHEL . (E-G) 1 .5 X 10 5 2114.11
and 1 .5 X 10 5 C10.9T cells were incubated together (MIX) in the absence of antigen (E), in
the presence of 300 Ag/ml of HEL (F), or in the presence of 100 AM pigeon fragment 81-
104 (G) . After 24 h the cells were stained with A2B4-2 and FITC-goatanti-mouse Ig so that
thetwo cell populations could be distinguished in mixed cultures.
use of the fact that the monoclonal antibody A2B4-2 can distinguish between
2B4.11 and C10 .9 . Correlated DNA/immunofluorescence analysis was per-
formed upon a mixture of these twoT cells in the presence ofno antigen, pigeon
fragment 81-104, or HEL (Fig . 4) . EachT cell divided rapidly when incubated
alone or in the presence of the otherT cell (Fig . 4, A, C, and E) . Surface staining
with A2B4-2 allowed the clear differentiation of the two cell populations, even
when they were mixed together (Fig . 4E). The addition of pigeon fragment 81-
104 to 2B4.11 and HEL to C10.9, resulted in predominantly a GI/S interface
block (Fig . 4, A vs . B; C vs .D) . The addition ofthese antigens to the inappropriate
cell had no effect on the cell cycle (data not shown) . Strikingly, in the mixed
population, the addition of HEL blocked the entry into S phase of virtually all
C10.9 T cells (A2B4-2-), while having almost no effect upon the cell cycle of
2134.11 T cells (A2B4-2+) (Fig . 4F). The reciprocal experiment, in which pigeon
fragment 81-104 was used to stimulate the mixed population, demonstrated a
marked cell cycle block of the 2B4.11 T cells, with virtually no effect upon theASHWELL ET AL.
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C10.9 T cells (Fig. 4G). This result demonstrates that the major effect of
stimulation with antigen is upon the antigen-specific T cell, and suggests that
soluble factors alone were not responsible for the cell cycle block.
Effect of Antigen Stimulation on T Cell Growth.
￿
To quantitate the effect of
antigenic stimulation upon the growth of T cell hybridomas, C10.9 or 2114.11
T cells were cultured in the presence of either B10.A APC, which bear both la
molecules required for the presentation of soluble antigen to these two T cell
hybrids, or B10.D2 APC, which do not bear the necessary allelic forms ofthe la
molecule . The T cell hybridomas were cultured in the presence or absence of
the appropriate antigens, and cell counts were performed at 24-h intervals (Fig.
5). C10.9 T cells grown in the presence of B10.A APC without antigen, or in
the presence of B10.D2 APC plus HEL, grew with a doubling time of ^"12 h
(Fig. 5A). In contrast, the growth of C10.9 T cells cultured in the presence of
B10.A APC and 300 ug/ml of HEL was markedly inhibited early in the course
ofthe culture. After a lag of^-4-5 d, the number of viable cells began to increase
exponentially, with a doubling time virtually identical to that displayed by the
unstimulated C10.9 Tcells. A similar result was obtained when this experiment
was performed with 2114.11 T cells (Fig. 5B). As with C10 .9, the unstimulated
2114.11 cells grew rapidly, with a doubling time of ^-13.5 h. The growth of
2114.11 T cells cultured in the presence of B10.A APC and 30 1M pigeon
fragment 81-104 was markedly slowed early in the course ofthe culture. Again,
after a lag of ^-4 d, the number of viable cells in the wells that had been
appropriately stimulated began to increase exponentially, with a doubling time
similar to that of the unstimulated 2B4.11 population . In another experiment
(Fig. 5C), the effect of different concentrations of antigen on cell growth was
determined. Little growth of2B4.11 was evident in the presence of 3 AM pigeon
fragment 81-104 until day 3, whereas its growth was delayed ^-1 d longer in the
presence of 100 )M antigen (the growth curve for 30 tM antigen [not shown]
was superimposable with that for 100,uM antigen).
Functional assays were performed to determine the responsiveness of those T
cells that had expanded after a lag period, despite the presence ofantigen. From
the experiment displayed in Fig. 5A, 10 independent wells from which C10 .9
cells had arisen after culture in the presence of B10.A APC and 300 'Ug/ml of
HEL were selected at random and expanded. All 10 of these sublines were
substantially less sensitive to antigenic stimulation than was the parent C10.9
clone, and on average appeared to be at least 100-fold more difficult to activate,
as judged both by IL-2 production and growth inhibition (Table IV). The
decreased sensitivity to antigen was a stable property. When these 10 C10.9
sublines were retested after 14 d (^-28 generations) with HEL concentrations of
up to 300 lag/ml, their responses were very similar to those given in Table IV,
with a mean decrease in [sH]thymidine incorporation ofonly 57% at the highest
concentration of antigen (data not shown). Thus, it appeared that the original
C10 .9 line contained a subpopulation(s) that was a relatively poor responder to
HEL, and whose growth was therefore not completely inhibited in the presence
of antigen. Given a doubling time of 12 h (Fig. 5A), it can be determined that
an antigen-resistant subpopulation of only 0.5% in the original C10.9 line could
account for the growth that was observed in the antigen-stimulated wells after 5184
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FIGURE 5.
￿
Growth of T cell hybridomas in the presence or absence of antigen/MHC. (A) 5
X 105 C10.9 T cells were incubated with 5 X 105 irradiated B10.A or BIO.D2 splenocytes in
the presence or absence of 300 kg/ml HEL. (p), BIO.A APC, no antigen; (/), B10.A APC,
HEL; (A), B10.D2 APC, HEL. (B) 5 X 10' 2114.11 T cells were incubated with 5 X 105
irradiated B10.A or B10.D2splenocytes in thepresence or absenceof 30 AM pigeon fragment
81-104. (0), B10.A APC; no antigen; (0), BIO.A APC; 81-104; (A), BIO.D2 APC; 81-104.
(C) 5 X 103 2114.11 T cells were incubated with 5 X 105 irradiated B10.A splenocytes and
either no, 3 AM, or 100 AM pigeon fragment 81-104. (p), No antigen; (/), 3 AM 81-104;
(A), 100 AM 81-104. Replicate wellswere resuspended daily and viable cell recovery assessed
by light microscopic examination in the presence of trypan blue dye. Each point represents
thearithmetic average of triplicate determinations.
d. Since both measurements of T cell activation (IL-2 production and growth
inhibition) were diminished, these sublines might have consisted of clones that
had lost a substantial portion of their antigen-specific receptors. It was not
possible to test this directly, because no anticlonotypic antibody exists for this T
cell. It was also possible that other molecules involved in the response to antigen
might have been lost by the resistant sublines. Indeed, flow cytometric analysis
performed with the anti-L3T4 antibody, GK1.5, revealed that, whereas the large
majority (91%) of the parent C10.9 T cells stained intensely with this antibody,ASHWELL ET AL.
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TABLE IV
Responsiveness ofC10.9 Sublines to Antigen/MHC
Number of C10.9
￿
Maximal [sHlthymidine incorporation (%) with HEL (Ag/ml):
sublines tested
￿
0
￿
1
￿
3
￿
10
￿
30
￿
100
A.
1 (no selection)*
￿
100
￿
50
￿
34
￿
41
￿
21
￿
8
10
￿
100 95±5$ 100±5 97±5 91±6 72±5
B.
￿
IL-2-production (U)
1 (no selection)*
￿
0
￿
3.5
￿
3.8
￿
6
￿
10
￿
15
10
￿
0 0.05±0.05* 0.4±0.27 1.1±0.4 1.9±0.37 3±0.56
Ten of the antigen-containing microtiter wells from the cell growth experiment shown in Fig. 5A,
in which 010.9 was cultured in the presence of HEL (300 kg/ml), were collected on day 6, and the
cells were expanded in growth medium alone. 4 d later, each C10.9 subline was tested for its ability
to produce IL-2 and to incorporate [sHlthymidine upon stimulation with HEL in the presence of
irradiated B10.A APC.
* The original C10.9 clone, carried in vitro, from whichthe sublines were derived.
t Mean ± SEM.
TABLE V
Responsiveness of 2B4.11 Sublines to Antigen/MHC
2134.11 sublines were established from independent microtiter wells on day 4 of the cell growth
experiment shown in Fig. 5C, in which 2B4.11 wascultured in the absence or presence ofpigeon
fragment 81-104 (3 or 100 AM). 7 d later each 2B4.11 subline was tested for itsability to produce
IL-2 and to incorporate [sHlthymidine upon stimulation with pigeon fragment 81-104 in the
presence of irradiated B10.A APC.
* Theoriginal 2134.11 clone, carried in vitro, from which thesublines were derived.
$ Sublines derived from microtiter wells in which no antigen wasadded.
Mean ± SEM.
only 9% of the C10.9 cells that had grown in antigen-containing wells bore the
L3T4 molecule .
An analysis performed with 2134.11 gave a similar, but quantitatively different,
result (Table V). Sublines of 2134.11 were established from the experiment
displayed in Fig. 5C. Five sublines that arose in the absence of antigen were as
sensitive to antigenic stimulation, as was the original 2134.11 clone carried in
Number Selecting Maximal [sHlthymidine incorporation (%)
of 2B4.11 antigen with pigeon fragment 81-104 (WM):
sublines concen-
tested tration 0 0.3 1 3 10 30
A.
1* None 100 34 22 10 7 5
5t None 100 34 ± 9 24 ± 2 12 ± 2 12 ± 2 5 ± 2
5 3WM 100 43±3 30±4 24±2 15±2 13±3
5 100uM 100 40±3 32±2 27±4 19±2 18±1
B. IL-2 production (U)
1* None 0 20 32 40 40 35
5$ None 0 16 ± 84 33 ± 10 57 ± 9 71 ± 11 69 ± 7
5 3 AM 0 17±1 33±4 36±6 43±4 43±5
5 100AM 0 10±2 13 t2 17 t2 13 t2 15±3186
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vitro, both in terms of their production of IL-2 and the inhibition of growth. At
their maximal response, sublines of 2114.11 that had been grown in the presence
of either 3 AM or 100 AM pigeon fragment 81-104 produced considerably less
IL-2 than did the sublines that had not been selected with antigen. The ability
of antigen to inhibit their incorporation of [3H]thymidine was also somewhat
decreased, especially at high concentrations ofantigen (i.e., the plateau inhibitory
response was less). Flow cytometric analysis and cell surface staining with the
anticlonotypic antibody A2114-2 showed that stimulation with increasing doses
of antigen did indeed select for receptor-negative variants of 2114.11 . On average,
the fraction of receptor-negative 2134.11 T cells, as a function of the concentra-
tion of pigeon fragment 81-104 used to select them, was: 0 gM, 3% ; 3 jM, 6%;
100 AM, 18%. The expression of L3T4 was not a useful parameter to follow for
these cells, since the parent clone bears negligible amounts of this molecule (data
not shown).
Failure to Reverse Cell Cycle Block 24 h after Removal of Antigen.
￿
These data
suggest that selection of relatively antigen-resistant cells does occur in the
presence of antigen, but also argue that in some cases a substantial number of
antigen-responsive cells can survive. This result is compatible with the hypothesis
that the cell cycle block is reversible, presumably allowing the inhibited cells to
resume their growth as the APC in the cultures die and become nonfunctional.
An alternative possibility is that, because of the requirement that a T cell must
encounter an antigen-presenting cell for stimulation to occur, a small number of
antigen-responsive 2134.11 T cellsmay simply have escapedsufficient stimulation
to be inhibited (with a doubling time of 13 .5 h the survival of ^-1 .5% and 6% of
the antigen-stimulated 2114.11 T cells could account for the growth patterns
depicted in Fig. 511 and C, respectively).
To directly test whether the cell cycle block was reversible, flow cytometric
cell cycle analysis was again used (Fig. 6) . The T cell C10.9 was incubated with
irradiated B10.A APC in the presence or absence of HEL. After 24 h the T cells
from both groups were separated from the APC by density centrifugation,
washed thoroughly, and placed back in culture in the presence of the anti-la
antibody 10-2.16 to ensure that any residual antigen-pulsed APC would not be
stimulatory (see Table II). In a separate antigen-stimulated group, the medium
was changed at 24 h and fresh antigen was added to maintain the stimulation.
After another 24 h, which would be enough time for two doublings of untreated
C10.9 T cells, cell growth cycle analysis was performed on each group (Fig. 6) .
The profile of cells incubated for 48 h in the absence of antigen was found to
contain ^"58% of the cells in GI, 40% in S, and 2% in G2 Plus M (Fig. 6A).
Incubation in the presence of continuous antigen inhibited the movement of
cells from G, to S phase (Fig. 611). -71% of the cells were found to be in GI,
27% in S, and 2% in G2 Plus M. A significant number of cells remained in S
phase, indicating either an incomplete GI/S block or an S phase cell cycle block,
as suggested above. The removal of the APC and antigen at 24 h had little if
anyeffect upon the degree of the GI/S cell cycle block measured at 48 h, because
this group was found to have a cell cycle profile nearly identical to that of cells
that were maintained in continuous antigen for 48 h (Fig. 6, B vs. C), with 86%
in GI, 13% in S, and 1 % in G2 Plus M. It can also be seen that the characteristicASHWELL ET AL .
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FIGURE 6 .
￿
Lack of reversibility of the G,/S block after 24 h. 10 5 C10.9 T cells/ml were
incubated with 5 x 106 irradiated B10.A splenocytes in the presence (B and C) or absence (A)
of 300 wg/ml HEL . (A) After 48 h theT cells were separated from the irradiated splenocytes
by density centrifugation, fixed with ethanol, and analyzed for DNA content . (B) 24 h after
the initiation of the cultures the medium was removed and replaced with fresh complete
medium containing 300 gg/ml HEL . After another 24 h theT cells were isolated by density
centrifugation and cell cycle analysis performed . (C) 24 h after the initiation of the cultures
the T cells were isolated by density centrifugation, washed three times, and placed back in
culture in fresh complete medium in the absence of antigen . A 1 :500 final concentration of
10-2.16-containing ascites was added to each tube to ensure that if a small number of APC
were carried over into the second cuture they would be unable to stimulate theT cells (see
Table 11) . After an additional 24 h of incubation, cell cycle analysis was performed. (D)
Superimposed profiles ofthe relative DNA content of the three C10.9 T cell populations: no
antigen (solid line), continuous antigen (dashed line), andantigen removed at 24 h (dotted line) .
cell size increase persisted in these cells 24 h after the removal of antigen .
Interestingly, the population of cells from which antigen was removed at 24 h
had fewer cells in S and correspondingly more in G I , suggesting that the S block
was at least partially reversible, its release allowing some of these cells to resume
cycling and to eventually be blocked at the G,/S interface . Thus, for at least the
large majority of theT cells, after 24 h of exposure to antigen theG I/S cell cycle
block appeared to be irreversible up to 24 h later . Similar results were obtained
with theT cell hybridoma 2134.11 (data not shown) . Taken together, these results
are compatible with the hypothesis that the eventual growth ofT cell hybridomas
after stimulation with antigen represents two phenomena : (a) the selection ofT
cell variants that are less sensitive to antigenic stimulation than the parent
population (most evident for CI0 .9, Table IV), and (b) the growth of a small188
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population of typically responsive T cells that were insufficiently stimulated in
the initial culture to develop a cell cycle block (e.g., 2134.11, Table V).
Discussion
T cell hybridomas have been used extensively in the study of the requirements
for, and the consequences of, T cell activation. One of the first, and still the
most common, assays used to assess the response ofa T cell hybridoma to a given
stimulus is to measure the culture supernatants for the presence of IL-2 (23).
Whereas most T cell hybrids do not produce IL-2 spontaneously, they secrete it
upon stimulation with a variety of agents, including lectin, antigen/MHC, and
crosslinked anticlonotypic antibodies (6, 23-25). In addition to IL-2, activated
T cell hybrids can produce a large variety of soluble factors upon stimula-
tion, including BSF-1 and other B cell proliferation and differentiation factors,
IFN-y, colony-stimulating factors, and lymphotoxin (26-30). In the present
report we have demonstrated that T cell hybridomas activated via the antigen-
specific receptor also develop a block in their cell growth cycle. The signals for
growth inhibition appeared to share the same recognition requirements as the
signals for lymphokine release. Further, the ability of anticlonotypic antibodies
crosslinked to an insoluble matrix, or antigen plus la molecules incorporated
into an artificial lipid planar membrane, to cause both IL-2 production and
growth inhibition demonstrated that no cell other than the responding T cell
hybrid was required to manifest this phenomenon .
The present report adds the antigen-specific T cell receptor to the growing
list ofreceptors whose occupancy, while functioning to promote growth in normal
cells, inhibits the growth of some transformed cell lines. For example, IL-2 is a
well-described stimulus of proliferation in normal T cells (31) . It was recently
observed that some spontaneously dividing human T cell leukemia virus-trans-
formed T cells ceased to grow in the presence of recombinant IL-2 (10). In
addition, exposure of a murine T cell line, transfected with the human IL-2
receptor gene, to recombinant IL-2 resulted in inhibition of its growth (11).
Another example is epidermal growth factor (EGF), which usually functions to
stimulate anchorage-independent growth in a variety of nontransformed cells
(32). Normally mitogenic concentrations of EGF inhibit the growth of the rat
pituitary cell line GH4CI (33), and the human epidermoid carcinoma A431, a
cell that bears an unusually high level of EGF receptors (8). A closely related
hormone, transforming growth factor type ,Q (TGF-(3), has also been found to
inhibit the anchorage-independent growth of a variety of tumor cells (9, 34) as
well as normal IL-2-stimulated human T cells (35).
There is also a striking parallel between the effect of antigen stimulation on
normal T cells and their hybrid counterparts and the effect of another lympho-
cyte-specific stimulus, antiimmunoglobulin (anti-1g), on normal B cells and some
B cell tumors. In normal resting murine B lymphocytes, crosslinking of surface
Ig with an appropriate anti-mouse Ig causes an increase in intracellular Cat+,
the breakdown of phosphatidylinositols, and the movement of resting cells into
the cell growth cycle (36-38). Anti-Ig treatment of some spontaneously dividing
B cell tumors, such as WEHI 231 (39, 40) and BCLI (41), on the other hand,
results in growth inhibition. In the case of WEHI 231 this is associated with aASHWELL ET AL.
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G,/S cell cycle block that, after ^-24-48 h, becomes irreversible and is followed
by cell death (42). Since WEHI 231 bears the phenotype of an immature B cell,
this phenomenon has been suggested as a model for the induction of tolerance
in immature B lymphocytes (42, 43). Bearing in mind that the Tcell hybridomas
used in the present report were prepared by fusing antigen-primed peripheral T
cells to a thymoma cell line, it is possible that the antigen-dependent cell cycle
block of T cell hybridomas may be related to tolerance induction in immature
T lymphocytes. This speculation obviously requires a considerably more thor-
ough understanding of how cellular activation via the antigen receptor occurs
before it can be directly examined.
In this regard it is worth considering the nature of the T cell growth cycle
block induced by antigenic stimulation. The major block was found to be at the
G,/S interface, with a second block in S phase itself. Removing the stimulus after
24 h and waiting another 24 h before analysis allowed some of the cells that
were trapped in S to resume cycling and to be subsequently blocked at G1/S.
The data presented in this study cannot exclude the possibility that the G,/S
block was reversible, but its release required more than 24 h in the absence of
antigen. It is also formally possible that the eventual growth of some antigen-
responsive 2114.11 T cells (Table V) was due to a leaky G,/S block, although this
would seem unlikely in view of the fact that the T cells that eventually grew in
the presence of continuous antigen did so with a doubling time identical to that
of unstimulated cells (Fig. 5). The simplest interpretation of the data is that the
cell cycle block is irreversible, and that the T cells that were found to grow after
a lag period represented either a small fraction that had escaped stimulation, or
those cells that, for any of a variety of reasons, were difficult to stimulate with
antigen/MHC. It is interesting to note that exposure of a variety of murine T
cell neoplasms, including BW5147 (44, 45) and a murine T cell hybridoma (23),
to lectins such as concanavalin A and phytohemagglutinin, has been shown to
lead to a decrease in DNA and RNA synthesis and eventually cell death. The
growth of both 2114.11 and C10.9 was also profoundly diminished after 24 h of
coculture with concentrations of concanavalin A that induced maximal IL-2
production from these cells (unpublished observation) . It is possible that lectin-
mediated cellular activation, perhaps by signalling through the antigen recep-
tor/T3 complex (46), delivers the same growth inhibitory signals as does anti-
gen/MHC, and may provide a means of studying this phenomenon in T cell
neoplasms for which the appropriate antigen/MHC combination is unknown.
A question ofparticular interest is how does antigen receptor occupancy result
in cell cycle blockade of T cell hybridomas? Experiments in which two T cell
hybridomas of different antigen specificities were cultured together in the
presence of a single antigen demonstrated that the cell cycle block occurred in
only the Tcell specific for that antigen (Figs. 3 and 4). It would therefore seem
unlikely that the T cell hybridomas produced, and were in turn inhibited by,
toxic lymphokines. However, these experiments do not rule out the possibility
that antigen activation resulted in two distinct events: the secretion of an
inhibitory lymphokine, and the expression ofthe receptor for that lymphokine.
One candidate for such a lymphokine/receptor pair would be the IL-2/IL-2
receptor combination (10, 11). We have ruled out this particular possibility by190
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the demonstration that the T cell hybridomas used in this study have few if any
IL-2 receptors, even when activated with antigen/MHC, and that the addition
of anti-IL-2 receptor antibodies to the cultures failed to prevent the growth
inhibition caused by antigen activation (unpublished results). However, the
possibility still exists that stimulation with antigen induced the expression of
some other inhibitory lymphokine and its receptor.
Finally, for completeness, it should be mentioned that some hematopoietic
neoplasms, such as erythroleukemia cells, can be induced to terminally differ-
entiateand therebycease their uncontrolled growth, by awide variety ofchemical
(e.g., dimethylsulfoxide, butyrate) andphysical (e.g., x and UV irradiation) agents
(47). Some myeloid leukemic cells can be similarly induced to differentiate in the
presence of colony stimulating factors (48). In view of the fact that normal
effector T lymphocytes do not seem to undergo terminal differentiation (e.g.,
mature and functionally competent T cells seem to have a virtually unlimited
capacity to renew themselves in vitro upon repetitive antigenic stimulation), and
that antigenic stimulation of T cell hybridomas results in an apparently irrever-
sible cell cycle blockand death, as judged by the release of "Cr (data not shown),
it seems unlikely that such an event accounts for the inhibition of growth in T
cell hybridomas . Furthermore, differentiation of hematopoietic cells is accom-
panied by a decrease in singular cell size (49); the increase in cell size accompa-
nying the GI/S block reported in the present study more likely reflects unbal-
anced growth leading to cell death, such as that due to deoxyadenosine GI arrest
of leukemic T cells (50).
The antigen-driven growth arrest of antigen-specific T cell hybridomas may
have some useful applications. As demonstrated in Fig. 1, as long as the T cell
hybrid population is fairly uniform in its ability to respond to antigen, the
measurement of the inhibition of growth is as sensitive and quantitative as the
measurement of IL-2 release. Moreover, the growth inhibition assay has a
number of distinct advantages over lymphokine assays; it is more rapid (requiring
-24 h vs. 48 h), does not require sequential cell cultures, and most importantly,
obviates the need to serially dilute supernatants to achieve quantitative results.
It should be noted, however, that because IL-2 is not produced by unactivated
T cell hybrids (i.e., the background activity is low), the detection of IL-2 in a
nonhomogeneous population might be more sensitive than the assessment of
growth inhibition . For example, the detection of a low level of IL-2 might
convincingly indicate that at least some small portion of the cells in a mixed
population had responded, whereas a small decrease in the incorporation of
[3H]thymidinemight be considered insignificant because of the high background,
resulting in a false negative .
Another potential use for the growth inhibition of antigen-stimulated T cell
hybrids is the selection of mutants in the activation/growth inhibition pathway.
As found with C10.9 and 2134.11, small subpopulations that are relatively
resistant to activation with antigen/MHC can continue to grow in the presence
of cells that are prevented from proliferating, although the experience with
2134.11 suggests that multiple rounds of selection may be necessary to allow
substantial expansion of such clones. Therefore, it should be possible to treat a
homogeneous in vitro line with mutagens and select for T cell hybridomas whoseASHWELL ET AL.
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growth is no longer inhibited by antigen/MHC. As demonstrated in this report,
such mutants and/or phenotypic variants should include T cells that have lost
molecules associated with the recognition of antigen (as with the antigen-specific
T cell receptor on 2B4.11, and the L3T4 molecule on C10.9). They would also
probably include cells in which the loss or modification of other molecule(s)
involved in antigen recognition and/or signal transduction (perhaps such as
elements of the T3 complex) had occurred, and might allow the separation of
the IL-2 secretory response from the growth inhibitory response. The generation
of such cells would be useful in the study of how antigen receptor occupancy
leads to lymphokine release and growth inhibition. Finally, the finding that the
activation of a variety of independently-derived T cell hybridomas can arrest
their growth raises the intriguing possibility that a therapeutic role might be
found for similar treatment of antigen-specific T cell tumors in vivo. Studies are
currently underway in our laboratory to investigate the potential of such treat-
ment in a model murine tumor system .
Summary
Stimulation of antigen-specific T cell hybridomas with the appropriate anti-
gen/MHC combination, at concentrations that resulted in the secretion of the
lymphokine interleukin 2, resulted in a dose-dependent decrease in both [sHJ-
thymidine incorporation and cell growth. Flow cytometric studies demonstrated
that stimulation with antigen resulted in a cell cycle block that was most evident
at the G,/S border, and mixing studies revealed that bystanderT cells of different
antigen specificities were not affected. For at least the large majority of T cells,
the G,/S cell cycle block appeared to be irreversible after 24 h of exposure to
antigen. This cell cycle block may be useful as a rapid and quantitative measure
of T cell hybridoma activation, as a means of selecting T cell hybridomas that
have functional alterations in the reception of stimulatory signals, and may serve
as a model of the induction of tolerance in immature T cells.
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